
Structure Therapeutics CEO Raymond Stevens Named to PharmaVoice 100
SAN FRANCISCO & SHANGHAI–(BUSINESS WIRE)–Structure Therapeutics, a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced that […]













